vTv Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

vTv Therapeutics

11/05/2023 22:10

* vTv Therapeutics Inc  VTVT.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 9 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * The mean earnings estimate of analysts had risen by
about 13.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * vTv Therapeutics Inc shares had risen by 15.1% this
quarter and
gained 40.3% so far this year.
    * The company reported a quarterly loss of $4.5 million.
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:10 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.09          -0.06          Beat
 Dec. 31 2022      -0.06          -0.06          Met
 Sep. 30 2022      -0.04          -0.05          Missed
 Jun. 30 2022      -0.09          -0.04          Beat